Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Verrica Pharmaceuticals Inc
(NQ:
VRCA
)
7.240
-0.010 (-0.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Verrica Pharmaceuticals Inc
< Previous
1
2
3
Next >
VRCA Investor Update: Robbins LLP Reminds Investors of Class Action Against Verrica Pharmaceuticals Inc. (VRCA)
June 13, 2022
From
Robbins LLP
Via
Business Wire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA)
June 13, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
Stockholder Alert: Robbins LLP Informs Investors of Class Action Against Verrica Pharmacuticals Inc. (VRCA)
June 11, 2022
From
Robbins LLP
Via
Business Wire
VRCA Stockholder News: Robbins LLP Investigates Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Stockholders
June 10, 2022
From
Robbins LLP
Via
Business Wire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA)
June 09, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
EQUITY ALERT: Rosen Law Firm Encourages Verrica Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – VRCA
June 08, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Verrica Pharmaceuticals, Inc. (VRCA) Investors
June 08, 2022
From
Kirby McInerney LLP
Via
Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Verrica Pharmaceuticals Inc. (VRCA) Investors
June 08, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Bronstein, Gewirtz & Grossman, LLC Notifies Verrica Pharmaceuticals Inc. (VRCA) Investors of Class Action and Encourages Investors to Contact the Firm
June 08, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm
June 08, 2022
From
The Schall Law Firm
Via
Business Wire
VERRICA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Verrica Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
June 07, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm
June 07, 2022
From
The Schall Law Firm
Via
Business Wire
VRCA CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Verrica Pharmaceuticals Inc.
June 07, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Verrica Pharmaceuticals Inc. (VRCA) Investors
June 06, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
VRCA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Verrica Pharmaceuticals Inc.
June 06, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
NASDAQ:VRCA Shareholder Notice: Investigation over Potential Securities Laws Violations by Verrica Pharmaceuticals Inc.
June 06, 2022
San Diego, CA -- (SBWIRE) -- 06/06/2022 -- Verrica Pharmaceuticals Inc is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
VERRICA ALERT: Bragar Eagel & Squire, P.C. is Investigating Verrica Pharmaceuticals, Inc. on Behalf of Verrica Stockholders and Encourages Investors to Contact the Firm
May 30, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
VERRICA ALERT: Bragar Eagel & Squire, P.C. is Investigating Verrica Pharmaceuticals, Inc. on Behalf of Verrica Stockholders and Encourages Investors to Contact the Firm
May 29, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Kirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of Verrica Pharmaceuticals Inc. (VRCA) Investors
May 27, 2022
From
Kirby McInerney LLP
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors
May 26, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors
May 26, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors
May 25, 2022
From
Law Offices of Frank R. Cruz
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.